Risk-weighted apoB: A Superior Predictor of Coronary Heart Disease Risk Beyond Traditional Lipid Measures
Coronary heart diseaseLipid biomarkersLipoprotein(a)Risk-weighted apoBTriglyceride-rich lipoproteins
Highlight
- Risk-weighted apoB (RW-apoB) is a novel lipid metric that integrates weighted contributions of LDL, triglyceride-rich lipoproteins (TRL/remnants), and lipoprotein(a) [Lp(a)] to better predict coronary heart disease (CHD) risk.
- RW-apoB reclassifies individual CHD risk significantly compared to apoB alone, identifying high-risk individuals who would otherwise be misclassified by traditional apoB measurements.
- RW-apoB consistently outperforms apoB and other traditional lipid biomarkers in risk prediction across multiple large population cohorts, including statin-treated subjects, reflecting its potential for guiding clinical decision-making.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.